These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5598540)

  • 21. [Abnormal lipid metabolism in nephrotic syndrome].
    Mizobata R; Mune M
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():152-5. PubMed ID: 11347048
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hyperlipemia in nephrotic syndrome].
    Walasek L
    Pol Tyg Lek; 1972 Jan; 27(5):189-91. PubMed ID: 4551652
    [No Abstract]   [Full Text] [Related]  

  • 23. [Lipid metabolism disorders in nephrotic syndrome].
    Walasek L
    Pol Tyg Lek; 1973 Nov; 28(46):1824-6. PubMed ID: 4771863
    [No Abstract]   [Full Text] [Related]  

  • 24. Pathogenesis of lipid abnormalities in patients with nephrotic syndrome/proteinuria: clinical implications.
    Warwick GL; Packard CJ
    Miner Electrolyte Metab; 1993; 19(3):115-26. PubMed ID: 8232098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Changes in the lipid metabolism in children with nephrotic syndrome].
    Matveev MP; Korovina NA
    Vopr Okhr Materin Det; 1968 Feb; 13(2):14-8. PubMed ID: 5720137
    [No Abstract]   [Full Text] [Related]  

  • 26. Lipids and progressive kidney disease.
    Moorhead JF
    Kidney Int Suppl; 1991 Apr; 31():S35-40. PubMed ID: 2046269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Activity of the clearing factor in the pathogenesis of hyperlipidemia in experimental nephrotic syndrome].
    Nikiforova NV
    Biull Eksp Biol Med; 1966 Dec; 62(12):29-32. PubMed ID: 6005418
    [No Abstract]   [Full Text] [Related]  

  • 28. Abnormalities of lipoprotein metabolism in the nephrotic syndrome.
    Bostom AG; Shemin D
    N Engl J Med; 1991 Mar; 324(10):697-8. PubMed ID: 1994257
    [No Abstract]   [Full Text] [Related]  

  • 29. Disorders of blood-lipids in renal disease.
    Cramp DG; Moorhead JF; Wills MR
    Lancet; 1975 Mar; 1(7908):672-3. PubMed ID: 47091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma lipoproteins and renal apolipoproteins in rats with chronic adriamycin nephrosis.
    Joles JA; van Tol A; Jansen EH; Koomans HA; Rabelink TJ; Grond J; van Goor H
    Nephrol Dial Transplant; 1993; 8(9):831-8. PubMed ID: 8255516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lipid metabolism disturbances in patients with nephrotic syndrome].
    Zdrojewski Z
    Pol Tyg Lek; 1993 May 17-31; 48(20-22):490-3. PubMed ID: 8170820
    [No Abstract]   [Full Text] [Related]  

  • 32. Hyperlipoproteinemia of aminonucleoside-induced nephrotic syndrome--modulation by glucocorticoids and triiodothyronine.
    Shafrir E
    Isr J Med Sci; 1996 Jun; 32(6):390-7. PubMed ID: 8682644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal apolipoproteins in nephrotic rats.
    van Goor H; van der Horst ML; Atmosoerodjo J; Joles JA; van Tol A; Grond J
    Am J Pathol; 1993 Jun; 142(6):1804-12. PubMed ID: 8506949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ADIPOSE TISSUE IN EXPERIMENTAL NEPHROTIC SYNDROME.
    GUTMAN A; SHAFRIR E
    Am J Physiol; 1963 Oct; 205():702-6. PubMed ID: 14060808
    [No Abstract]   [Full Text] [Related]  

  • 35. Tissue lipoprotein lipase, serum, and urinary lipids and lipoproteins in experimental glomerulonephritis of rats (Heymann's nephritis).
    Van Zoeren D; Adams LE; Hynd BA; Hess EV; Kashyap ML
    Biochem Med; 1981 Jun; 25(3):260-6. PubMed ID: 7271761
    [No Abstract]   [Full Text] [Related]  

  • 36. Lipid abnormalities in chronic renal failure, nephrotic syndrome and dialysis.
    Kes P
    Acta Med Croatica; 2001; 55(4-5):177-86. PubMed ID: 12398021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Lipid and lipoprotein studies in nephrotic syndrome cases in childhood].
    László A; Havass Z; Joó I; Bodrogi T; Turi S
    Kinderarztl Prax; 1985 Apr; 53(4):199-203. PubMed ID: 4010160
    [No Abstract]   [Full Text] [Related]  

  • 38. Lipid abnormalities in the nephrotic syndrome: the therapeutic role of statins.
    Wheeler DC
    J Nephrol; 2001; 14 Suppl 4():S70-5. PubMed ID: 11798150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Some changes in the metabolism of lipids in kidney diseases. I. Nephrotic syndrome].
    KUCEROVA L; STORK A
    Cas Lek Cesk; 1962 May; 101():618-23. PubMed ID: 14460146
    [No Abstract]   [Full Text] [Related]  

  • 40. Protective role of sulphated polysaccharides in abating the hyperlipidemic nephropathy provoked by cyclosporine A.
    Josephine A; Veena CK; Amudha G; Preetha SP; Varalakshmi P
    Arch Toxicol; 2007 May; 81(5):371-9. PubMed ID: 17019561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.